Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Certolizumab pegol 200mg/1ml inj pre-filled syringes
1001030Y0AAAAAA
|
Certolizumab pegol | Certolizumab pegol | Musculoskeletal and Joint Diseases | No data available |
|
Cimzia 200mg/1ml inj in a dose-dispenser cartridge
1001030Y0BBACAC
|
Cimzia | Certolizumab pegol | Musculoskeletal and Joint Diseases | No data available |
|
Cimzia 200mg/1ml solution for injection pre-filled pens
1001030Y0BBABAB
|
Cimzia | Certolizumab pegol | Musculoskeletal and Joint Diseases | No data available |
|
Clinoril 100mg tablets
1001010S0BBAAAA
|
Clinoril | Sulindac | Musculoskeletal and Joint Diseases | No data available |
|
Clinoril 200mg tablets
1001010S0BBABAB
|
Clinoril | Sulindac | Musculoskeletal and Joint Diseases | No data available |
|
Closteril 100 modified-release tablets
1001010C0CGAAAF
|
Closteril | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Codafen Continus tablets
1001010J0B8AAAR
|
Codafen Continus | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Cosentyx 150mg/1ml inj pre-filled syringes
1001030AFBBABAB
|
Cosentyx | Secukinumab | Musculoskeletal and Joint Diseases | No data available |
|
Cosentyx 150mg/1ml solution for injection pre-filled pens
1001030AFBBAAAA
|
Cosentyx | Secukinumab | Musculoskeletal and Joint Diseases | No data available |
|
Cosentyx 300mg/2ml solution for injection pre-filled pens
1001030AFBBACAC
|
Cosentyx | Secukinumab | Musculoskeletal and Joint Diseases | No data available |
|
Cosentyx 75mg/0.5ml inj pre-filled syringes
1001030AFBBADAD
|
Cosentyx | Secukinumab | Musculoskeletal and Joint Diseases | No data available |
|
Cozachew Fizz 1500mg effervescent tablets
1001050A0BPAAAK
|
Cozachew Fizz | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Cozachew Fizz Combi 500mg/400mg effervescent tablets
1001050A0BQAAAL
|
Cozachew Fizz Combi | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Cozachew Meltdown 1500 chewable tablets
1001050A0BEAAAC
|
IXL Pharma (Glucosamine hydrochloride) | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Cozachew Meltdown Combi 500mg/400mg chewable tablets
1001050A0BEADAD
|
IXL Pharma (Glucosamine hydrochloride) | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Cremalgin Balm ointment
1003020T0BFAAAD
|
Cremalgin | Nicotinates | Musculoskeletal and Joint Diseases | No data available |
|
Cuprofen 200mg tablets
1001010J0BMAAAD
|
Cuprofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Cuprofen 5% gel
1003020P0BJAAAC
|
Cuprofen (Topical) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Cuprofen for Children 100mg/5ml oral suspension
1001010J0BMADBH
|
Cuprofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Cuprofen PLUS tablets
1001010J0BMAEAY
|
Cuprofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Cytoplan Glucosamine hydrochloride 750mg capsules
1001050A0CDAAAM
|
Cytoplan (Glucosamine hydrochloride) | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Dantrolene 100mg/5ml oral solution
1002020J0AABIBI
|
Dantrolene sodium (Systemic) | Dantrolene sodium | Musculoskeletal and Joint Diseases | No data available |
|
Dantrolene 10mg/5ml oral solution
1002020J0AAAXAX
|
Dantrolene sodium (Systemic) | Dantrolene sodium | Musculoskeletal and Joint Diseases | No data available |
|
Dantrolene 15mg/5ml oral liquid
1002020J0AABCBC
|
Dantrolene sodium (Systemic) | Dantrolene sodium | Musculoskeletal and Joint Diseases | No data available |
|
Dantrolene 16.67mg/5ml oral liquid
1002020J0AAAWAW
|
Dantrolene sodium (Systemic) | Dantrolene sodium | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.